KENILWORTH, N.J.–(BUSINESS WIRE) August 30, 2018 –Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced
Continue reading »
FDA Approves First Generic EpiPen
FRIDAY, Aug. 17, 2018 — The first generic version of the EpiPen has been approved by the U.S. Food and
Continue reading »
FDA approves tibsovo for acute myeloid leukemia
(HealthDay)—Tibsovo (ivosidenib) tablets have been approved by the U.S. Food and Drug Administration to treat relapsed or refractory acute myeloid
Continue reading »
FDA Approves Symtuza
TITUSVILLE, N.J, JULY 17, 2018 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the U.S. Food and
Continue reading »
FDA Approves Continuous Glucose Monitoring System
THURSDAY, June 28, 2018 — The Eversense Continuous Glucose Monitoring (CGM) system, which has a fully implantable sensor to detect
Continue reading »
FDA approves non-opioid treatment for opioid withdrawal
(HealthDay)—Lucemyra (lofexidine hydrochloride) has been approved by the U.S. Food and Drug Administration to treat symptoms of opioid withdrawal. Lucemyra,
Continue reading »
Congo approves use of experimental Ebola vaccine, WHO says
The Director-General of the World Health Organization says Congo officials have agreed to use an experimental Ebola vaccine. Tedros Adhanom
Continue reading »
Michigan approves ban on antidepressant tianeptine sodium
Michigan’s governor has signed what’s been described by state police as the nation’s first statewide ban on the antidepressant tianeptine
Continue reading »